Supervisory Board

DDr. Manfred Reichl (Chairman)

Entrepreneur, investor, business angel (“Austrian Business Angel of the Year 2009”), and Senior Adviser to renowned global institutions (e.g. UBS Investment Bank, World Economic Forum). >20 years of experience in international strategic consulting as Senior Managing Partner at Roland Berger, heading Austria and Eastern Europe for more than 15 years. European Program Manager for a Computer Line at Hewlett Packard. Lecturer in Vienna respectively Munich on “Corporate Governance”, “China”, and “Globalization”.

Mag. Rainer C. Burian

Rainer C. Burian was managing director of an Austrian based life science investment holding and afterwards founded PAA Laboratories in 1988. He developed the company from a small local lab to a leading global supplier of cell culture products to the biopharmaceutical industry with subsidiaries on four continents. Several company prizes were awarded to PAA under his leadership. In 2011, he sold the company to a multinational pharma corporation and became a successful investor and entrepreneur with extensive experience in the pharmaceutical and biotech industry. Rainer holds a Master in Business Administration (Mag.) from Vienna University of Economics and Business.

Josef Penninger, MD

Founder of Apeiron. Studied Medicine & Arts at the University Innsbruck, since 1990 worked as post-doctoral fellow at the Ontario Cancer Institute. Author of > 400 publications and patents; ranked twice among top 10 most cited scientists globally. Worked for 13 years with Amgen, the Ontario Cancer Institute and University of Toronto. Former Scientific Director of the IMBA in Vienna (2002 until 2018), now Scientific Director and Professor of the Life Science Institute of the University of British Columbia.

Erwin Rasinger, MD

Austrian physician and politician. Studied Medicine and Business Administration in Vienna. Referee for ecology of the Medical Association of Austria. Member of Austrian National Assembly from 1994 until 2017.

Dr. Helmut Schuehsler

VC and deal maker on more than 30 direct investments in life science companies in Europe and the U.S. Has overseen more than 100 investments in the life science industry. Built the TVM Capital Life Science practice as an internal start up within TVM Capital.